Deferasirox Tablet, For Suspension
Product Images NDC 68462-494

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 68462-494). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl125mg30s.jpg (Lbl125mg30s)

Deferasirox Tablets for Oral Suspension, 125 mg strength, in a 30 tablet package from Glenmark Pharmaceuticals Inc., USA. The label includes storage and handling instructions, a warning not to chew or swallow whole, and pharmacist dispensing advice. The NDC is 68462-494-30.*

FDA Label Image

Lbl250mg30s.jpg (Lbl250mg30s)

Deferasirox 250 mg tablets for oral suspension label showing medication name, strength, and instructions. The label indicates dispensing information for pharmacists, including not to chew or swallow whole tablets. It includes Glenmark Pharmaceuticals Inc., USA as the labeler and a 30-tablet package size. Additional usage and storage instructions are visible.*

FDA Label Image

Lbl500mg30s.jpg (Lbl500mg30s)

Label for Deferasirox Tablets for Oral Suspension 500 mg by Glenmark Pharmaceuticals Inc. The label includes dispensing instructions, storage conditions, and pharmacist guidance. The package contains 30 tablets, with directions not to chew or swallow whole, emphasizing the tablets must be dispersed in water, orange, or apple juice before ingestion. The label also features a barcode and manufacturing details.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure diagram of deferasirox, showing the molecular configuration with three connected rings and hydroxyl and carboxyl functional groups.*

FDA Label Image

Figure1.jpg (Figure1)

A bar graph comparing the change in liver iron content and serum ferritin levels at various doses of deferasirox tablets (5, 10, 20, and 30 mg/kg/day). Liver iron content is shown with white bars, serum ferritin with black bars. Sample sizes are indicated below each dose. The y-axes show change in liver iron content (mg Fe/g dry weight) on the left and change in serum ferritin (mcg/L) on the right.*

FDA Label Image

Logo.jpg (Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.